Synergy CHC Corp. Common Stock (SNYR) - Net Assets
Based on the latest financial reports, Synergy CHC Corp. Common Stock (SNYR) has net assets worth $-25.17 Million USD as of September 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($12.17 Million) and total liabilities ($37.34 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-25.17 Million |
| % of Total Assets | -206.81% |
| Annual Growth Rate | N/A |
| 5-Year Change | -787.69% |
| 10-Year Change | N/A |
| Growth Volatility | 107.37 |
Synergy CHC Corp. Common Stock - Net Assets Trend (2012–2023)
This chart illustrates how Synergy CHC Corp. Common Stock's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Synergy CHC Corp. Common Stock (2012–2023)
The table below shows the annual net assets of Synergy CHC Corp. Common Stock from 2012 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-27.31 Million | +18.54% |
| 2022-12-31 | $-33.52 Million | -809.85% |
| 2020-12-31 | $-3.68 Million | +29.20% |
| 2019-12-31 | $-5.20 Million | -231.04% |
| 2018-12-31 | $3.97 Million | -57.91% |
| 2017-12-31 | $9.43 Million | +32.72% |
| 2016-12-31 | $7.11 Million | +31.14% |
| 2015-12-31 | $5.42 Million | +4412.79% |
| 2014-12-31 | $-125.67K | -880.16% |
| 2013-12-31 | $-12.82K | +8.42% |
| 2012-12-31 | $-14.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Synergy CHC Corp. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4632724200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $899.00 | % |
| Other Comprehensive Income | $-102.47K | % |
| Other Components | $19.15 Million | % |
| Total Equity | $-27.31 Million | 100.00% |
Synergy CHC Corp. Common Stock Competitors by Market Cap
The table below lists competitors of Synergy CHC Corp. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BIO-Key International Inc
NASDAQ:BKYI
|
$5.38 Million |
|
Intouch Insight Ltd
OTCQX:INXSF
|
$5.38 Million |
|
Superbag Company Limited
PINK:SUPBF
|
$5.38 Million |
|
Oncosil Medical Ltd
AU:OSL
|
$5.38 Million |
|
Lion Metal Works Tbk
JK:LION
|
$5.38 Million |
|
LONZA GRP N - Dusseldorf Stock Exchang
DU:LO3
|
$5.37 Million |
|
Tainwala Chemical and Plastic (I) Limited
NSE:TAINWALCHM
|
$5.37 Million |
|
Gale Pacific Ltd
AU:GAP
|
$5.37 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Synergy CHC Corp. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -33,519,866 to -27,305,973, a change of 6,213,893.
- Net income of 6,338,750 contributed positively to equity growth.
- Other comprehensive income decreased equity by 124,856.
- Other factors decreased equity by 1.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $6.34 Million | +23.21% |
| Other Comprehensive Income | $-124.86K | -0.46% |
| Other Changes | $-1.00 | -0.0% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Synergy CHC Corp. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $0.00 | $2.30 | x |
| 2013-12-31 | $0.00 | $2.30 | x |
| 2014-12-31 | $0.00 | $2.30 | x |
| 2015-12-31 | $0.08 | $2.30 | x |
| 2016-12-31 | $0.09 | $2.30 | x |
| 2017-12-31 | $0.11 | $2.30 | x |
| 2018-12-31 | $0.04 | $2.30 | x |
| 2019-12-31 | $-0.06 | $2.30 | x |
| 2020-12-31 | $-0.04 | $2.30 | x |
| 2022-12-31 | $-0.37 | $2.30 | x |
| 2023-12-31 | $-0.30 | $2.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Synergy CHC Corp. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.82%
- • Asset Turnover: 3.50x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-27.28%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-14.80K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-21.92K |
| 2014 | 0.00% | -10483.64% | 0.17x | 0.00x | $-947.53K |
| 2015 | -139.06% | -56.01% | 0.50x | 5.01x | $-8.08 Million |
| 2016 | -11.20% | -2.29% | 1.70x | 2.88x | $-1.51 Million |
| 2017 | 5.30% | 1.40% | 1.48x | 2.55x | $-443.76K |
| 2018 | -155.15% | -18.21% | 1.69x | 5.04x | $-6.56 Million |
| 2019 | 0.00% | -31.36% | 5.66x | 0.00x | $-8.69 Million |
| 2020 | 0.00% | 3.51% | 3.20x | 0.00x | $1.78 Million |
| 2022 | 0.00% | -84.95% | 2.07x | 0.00x | $-29.28 Million |
| 2023 | 0.00% | 14.82% | 3.50x | 0.00x | $9.07 Million |
Industry Comparison
This section compares Synergy CHC Corp. Common Stock's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,289,371,716
- Average return on equity (ROE) among peers: 16.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Synergy CHC Corp. Common Stock (SNYR) | $-25.17 Million | 0.00% | N/A | $5.38 Million |
| Accendra Health Inc (ACH) | $547.45 Million | 8.91% | 2.08x | $24.99K |
| Arjo AB (publ) (ARRJF) | $10.66 Billion | 4.60% | 0.38x | $491.29 Million |
| Cardinal Health Inc (CAH) | $-706.00 Million | 0.00% | 0.00x | $50.68 Billion |
| Cencora Inc. (COR) | $2.13 Billion | 67.06% | 14.77x | $60.03 Billion |
| Cosmos Health Inc. (COSM) | $-3.32 Million | 0.00% | 0.00x | $7.38 Million |
| EDAP TMS SA (EDAP) | $24.45 Million | 15.71% | 0.91x | $95.77 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $1.53 Million | 49.22% | 2.01x | $9.16 Million |
| Energy Management International Inc (ENMI) | $-365.00K | 0.00% | 0.00x | $383.13K |
| Exlites Holdings International Inc (EXHI) | $2.30 Million | -17.39% | 0.17x | $574.58K |
| Galenica AG (GALNF) | $240.26 Million | 34.06% | 6.11x | $3.75 Billion |
About Synergy CHC Corp. Common Stock
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name; products for hands un… Read more